The developments at Holland Capital in 2024 reflect our strong ambitions
Amsterdam/ Düsseldorf, 30th of December 2024 –The developments at Holland Capital in 2024 reflect our strong ambitions. Guided by a focused investment strategy, we continued to actively engage in the high-growth markets of Technology, Healthcare, and Agrifood. Reflecting on a successful year, we completed several key transactions and further strengthened our team.
2024 achievements
- The launch of our fund, Holland Capital Growth and Buy-Out Fund V
- Number of deals in the Netherlands: 5
- Number of add-on acquisitions in the Netherlands: 13
- Number of add-on acquisitions in Germany: 2
- Number of exits: 2
- Number of new colleagues: 4
Sector focus and an entrepreneurial hands-on approach: With specialized sector teams, we focus on the sectors of Healthcare, Technology, and Agrifood, both within the Growth & Buy-out and Venture & Growth segments. We understand the dynamics and opportunities in these sectors and have an extensive network. Holland Capital is not a passive investor; we work closely with management to define and execute strategies. Where needed, our operational team also contributes hands-on to the realization of specific projects within the company.
Which companies would we like to connect with?
- Sector: Technology, Healthcare, and Agrifood
- Positive outlook: Significant growth potential, both autonomous and buy-and-build
- Growth & Buy-out:
- Healthy profitability: cash flow from operations (EBITDA) between EUR 1 – 10m
- Smaller companies: considered as add-on acquisitions for our existing portfolio companies
- Larger companies: considered together with a co-investor
- Venture & Growth:
- Start-ups and scale-ups: EBITDA EUR <1m
- Cash flow negative (in an accelerated growth scenario)
- Revenue EUR 0 – 5m
What to expect from us?
- Flexible approach to transaction structures: We strive to adapt each structure to the needs of the company and its shareholders. Depending on the type of investment, Holland Capital either provides growth capital and/or acquires existing shares. We are flexible regarding the final capital structure: both majority and minority stakes are possible.
- Deal certainty and an efficient process: Thanks to our sector expertise, we are able to quickly assess a business model and put a fair price on the table. Since the partnership with the entrepreneur and/or the management team is the cornerstone of our investment, we devote above-average attention to ensuring the process is completed efficiently, in the right spirit, and with mutual respect for both parties.
- Transparency towards advisors: We appreciate it when advisors involve us early in discussions with entrepreneurs and/or management teams. In such cases, we always ensure that the advisor’s interests are well safeguarded throughout the process. The advisor retains the flexibility to decide whether to represent the sell-side or buy-side in a potential transaction.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare, Technology, and Agrifood-Tech sector.
Highcare expands its services to the mental health sector through the acquisition of Buro MK
Highcare expands its services to the mental health sector through the acquisition of Buro MK Roosendaal / Zutphen, 26th of April 2019 - Highcare acquires Buro MK, an employment agency specialized in the deployment of mental healthcare professionals (GGZ). With this...
Highcare breidt dienstverlening uit naar GGZ-sector door overname Buro MK
Roosendaal/Zutphen, 25 april 2019 – Highcare neemt Buro MK, een uitzendbureau gespecialiseerd in het uitzenden van zorgprofessionals in de geestelijke gezondheidszorg (GGZ), over. Met deze overname breidt Highcare haar dienstverlening uit naar een specifieke...
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei Eindhoven, 25 maart 2019 - CytoSMART, de Eindhovense ontwikkelaar en fabrikant van digitale microscopen voor het monitoren van celkweekprocessen, ontvangt een groeifinanciering van 5,2 miljoen euro....
CytoSMART raises 5.2 million euros for further product innovation and growth
CytoSMART raises 5.2 million euros for further product innovation and growth Eindhoven, 25th of March - CytoSMART, the Eindhoven-based company that develops and manufactures digital microscopes for monitoring live cell cultures, has received 5.2 million euros to fund...
ETTU en Wortell fuseren vanuit ambitie beste Microsoft Cloud Solution Partner te worden
ETTU en Wortell fuseren vanuit ambitie beste Microsoft Cloud Solution Partner te worden Amsterdam, 7 maart 2019 - De ICT-dienstverleners Wortell uit Lijnden en ETTU uit Gouda bundelen de krachten en gaan samen verder onder de naam Wortell. Met de fusie wordt een...
Merger ETTU and Wortell reflects ambition to become the best Microsoft Cloud Solution Partner
Merger ETTU and Wortell reflects ambition to become the best Microsoft Cloud Solution Partner Amsterdam, 7 March 2019 - The IT service providers Wortell from Lijnden and ETTU from Gouda join forces and continue together under the name of Wortell. The merger creates a...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl